INTRODUCING OXIMO
A Novel Therapeutic Approach for Herpes
INTRODUCING OXIMO
A Novel Therapeutic Approach for Herpes
INTRODUCING OXIMO
A Novel Therapeutic Approach for Herpes
MISSION
We are dedicated to delivering efficient and reliable solutions for the treatment of patients infected with Herpes Simplex Virus, with a particular focus on conditions that cause the most significant medical, psychological, and social distress.
MISSION
We are dedicated to delivering efficient and reliable solutions for the treatment of patients infected with Herpes Simplex Virus, with a particular focus on conditions that cause the most significant medical, psychological, and social distress.
MISSION
We are dedicated to delivering efficient and reliable solutions for the treatment of patients infected with Herpes Simplex Virus, with a particular focus on conditions that cause the most significant medical, psychological, and social distress.
OUR OUT OF THE BOX APPROACH
Our invention generates the production of specific Reactive Oxygen Species (ROS) that are delivered at the right place, dose and time.
Directly targeting HSV
Oximo inactivates HSV both extracellularly and intracellularly by generating specific Reactive Oxygen Species (ROS), disrupting viral particles and halting replication, ensuring a comprehensive antiviral activity throughout the infection pathway.
Blocking HSV entry
Oximo targets and disrupts heparan sulfate receptors on cell surfaces, effectively preventing HSV from attaching and entering cells. This innovative approach stops infection at the earliest stage.
OUR OUT OF THE BOX APPROACH
Our invention generates the production of specific Reactive Oxygen Species (ROS) that are delivered at the right place, dose and time.
Directly targeting HSV
Oximo inactivates HSV both extracellularly and intracellularly by generating specific Reactive Oxygen Species (ROS), disrupting viral particles and halting replication, ensuring a comprehensive antiviral activity throughout the infection pathway.
Blocking HSV entry
Oximo targets and disrupts heparan sulfate receptors on cell surfaces, effectively preventing HSV from attaching and entering cells. This innovative approach stops infection at the earliest stage.
OUR OUT OF THE BOX APPROACH
Our invention generates the production of specific Reactive Oxygen Species (ROS) that are delivered at the right place, dose and time.
Directly targeting HSV
Oximo inactivates HSV both extracellularly and intracellularly by generating specific Reactive Oxygen Species (ROS), disrupting viral particles and halting replication, ensuring a comprehensive antiviral activity throughout the infection pathway.
Blocking HSV entry
Oximo targets and disrupts heparan sulfate receptors on cell surfaces, effectively preventing HSV from attaching and entering cells. This innovative approach stops infection at the earliest stage.
NEWS
Latest Updates from OXYMO
NEWS
Latest Updates from OXYMO
NEWS
Latest Updates from OXYMO
CONTACT
Our primary goal is to deliver an innovative approach to stop herpetic episodes at the prodromal phase
We aim to effectively prevent the formation of blisters and lesions, thereby providing treatment for HSV-infected patients. Reach out to learn more.
CONTACT
Our primary goal is to deliver an innovative approach to stop herpetic episodes at the prodromal phase
We aim to effectively prevent the formation of blisters and lesions, thereby providing treatment for HSV-infected patients. Reach out to learn more.
CONTACT
Our primary goal is to deliver an innovative approach to stop herpetic episodes at the prodromal phase
We aim to effectively prevent the formation of blisters and lesions, thereby providing treatment for HSV-infected patients. Reach out to learn more.